Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of DR4 (TRAIL-R1) polymorphisms with cancer risk in Caucasians: an updated meta-analysis.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2014

Chen Wei, Tang Wen-Ru, Zhang Ming, Chang Kwenjen, Wei Yun-Lin

Abstract excerpt

Death receptor 4 (TRAIL-R1 or DR4) polymorphisms have been associated with cancer risk, but findings have been inconsistent. To estimate the relationship in detail, a meta-analysis was here performed. A search of PubMed was conducted to investigate the association between DR4 C626G, A683C and A1322G polymorphisms and cancer risk, using odds ratios (ORs) with 95% confidence intervals. The results suggested that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Polymorphism, Genetic

Share to Prognosis

Share to Receptors, TNF-Related Apoptosis-Inducing Ligand

Share to Risk Factors

Share to White People

Source

Identifiers

PMID: 24761920
DOI: 10.7314/apjcp.2014.15.6.2889

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of DR4 (TRAIL-R1) polymorphisms with cancer risk in Caucasians: an updated meta-analysis.PMID 24761920Read ↗

TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis.Semantic proximity Read ↗

Association of four polymorphisms in the death receptor 4 gene with cancer risk: an updated meta-analysis.Semantic proximity Read ↗

Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population.Semantic proximity Read ↗

Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriers.Semantic proximity Read ↗

Association of polymorphisms in TRAIL1 and TRAILR1 genes with susceptibility to lymphomas.Semantic proximity Read ↗

Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.Semantic proximity Read ↗

Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.Semantic proximity Read ↗

Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt.Semantic proximity Read ↗

Associations of PD-1 and PD-L1 gene polymorphisms with cancer risk: a meta-analysis based on 50 studies.Semantic proximity Read ↗

A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan.Semantic proximity Read ↗

Death receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian population.Semantic proximity Read ↗

Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.